Potentiation of cyclic AMP-mediated proopiomelanocortin gene promoter activity by calcium channel blockers in a pituitary cell line

European Journal of Pharmacology

Volumn 558, Issue 1-3, 2007, Pages 1-6

  Ikeda, Masahiro ^a   Kakuyama, Masahiro ^a   Shoda, Takehiro ^a   Iwasaki, Yasumasa ^b   Fukuda, Kazuhiko ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KOCHI UNIVERSITY   (Japan)

Author keywords

Calcium channel blocker; Cyclic AMP; Pituitary; Promoter activity; Proopiomelanocortin

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; DILTIAZEM; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; NIFEDIPINE; PHOSPHODIESTERASE; POTASSIUM CHLORIDE; PROOPIOMELANOCORTIN; VERAPAMIL;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; DRUG PROTEIN BINDING; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSFECTION; HORMONAL REGULATION; HYPOPHYSIS CELL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CALCIUM CHANNEL BLOCKERS; CELL LINE; CORTICOTROPIN-RELEASING HORMONE; CYCLIC AMP; FORSKOLIN; MICE; PITUITARY GLAND; PRO-OPIOMELANOCORTIN; PROMOTER REGIONS (GENETICS);

EID: 33847259190     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.11.038     Document Type: Article

References (23)

1. Ang K.L., and Antoni F.A. Functional plasticity of cyclic AMP hydrolysis in rat adenohypophysial corticotroph cells. Cell. Signal. 14 (2002) 445-452
2. Aoki Y., Iwasaki Y., Katahira M., Oiso Y., and Saito H. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. I: Effects of the common secretagogues. Endocrinology 138 (1997) 1923-1929
3. Boutillier A.L., Gaiddon C., Lorang D., Roberts J.L., and Loeffler J.P. Transcriptional activation of the proopiomelanocortin gene by cyclic AMP-responsive element binding protein. Pituitary 1 (1998) 33-43
4. Dave J.R., Eiden L.E., Lozovsky D., Waschek J.A., and Eskay R.L. Calcium-independent and calcium-dependent mechanisms regulate corticotropin-releasing factor-stimulated proopiomelanocortin peptide secretion and messenger ribonucleic acid production. Endocrinology 120 (1987) 305-310
5. Drouin J., Chamberland M., Charron J., Jeannotte L., and Nemer M. Structure of the rat pro-opiomelanocortin (POMC) gene. FEBS Lett. 193 (1985) 54-58
6. Fiekers J.F., Gelbspan D., and Heppner T.J. Calcium homeostasis in a clonal pituitary cell line of mouse corticotropes. Can. J. Physiol. Pharmacol. 79 (2001) 502-511
7. Fukuda K., Uetsuki N., Uga H., Hashiguchi M., Sato M., Hisano T., Segawa H., and Iwasaki Y. Potentiation of proopiomelanocortin gene expression in cultured pituitary cells by benzodiazepines. Anesthesiology 98 (2003) 1172-1177
8. Katahira M., Iwasaki Y., Aoki Y., Oiso Y., and Saito H. Cytokine regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. Endocrinology 139 (1998) 2414-2422
9. Kumari M., Cover P.O., Poyser R.H., and Buckingham J.C. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies. Br. J. Pharmacol. 121 (1997) 459-468
10. 2+ channels in rat corticotropes. Endocrinology 137 (1996) 2269-2277
11. Levin N., and Roberts J.L. Positive regulation of proopiomelanocortin gene expression in corticotropes and melanotropes. Front. Neuroendocrinol. 12 (1991) 1-22
12. Litvin Y., PasMantier R., Fleischer N., and Erlichman J. Hormonal activation of the cAMP-dependent protein kinases in AtT20 cells. Preferential activation of protein kinase I by corticotropin releasing factor, isoproterenol, and forskolin. J. Biol. Chem. 259 (1984) 10296-10302
13. Luini A., Lewis D., Guild S., Corda D., and Axelrod J. Hormone secretagogues increase cytosolic calcium by increasing cAMP in corticotropin-secreting cells. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 8034-8038
14. Maurice D.H., Palmer D., Tilley D.G., Dunkerley H.A., Netherton S.J., Raymond D.R., Elbatarny H.S., and Jimmo S.L. Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system. Mol. Pharmacol. 64 (2003) 533-546
15. Minocherhomjee A.E., and Roufogalis B.D. Antagonism of calmodulin and phosphodiesterase by nifedipine and related calcium entry blockers. Cell Calcium 5 (1984) 57-63
16. Moore Jr. J.B., Fuller B.L., Falotico R., and Tolman E.L. Inhibition of rabbit platelet phosphodiesterase activity and aggregation by calcium channel blockers. Thromb. Res. 40 (1985) 401-411
17. Nikodemova M., Kasckow J., Liu H., Manganiello V., and Aguilera G. Cyclic adenosine 3′,5′-monophosphate regulation of corticotropin-releasing hormone promoter activity in AtT-20 cells and in a transformed hypothalamic cell line. Endocrinology 144 (2003) 1292-1300
18. Nomura A., Iwasaki Y., Aoki Y., Yamamori E., Mutsuga N., Yoshida M., Asai M., Oiso Y., and Saito H. Effects of loperamide and other opioid-related substances on the transcriptional regulation of the rat pro-opiomelanocortin gene in AtT20 cells. Neuroendocrinology 74 (2001) 87-94
19. Raemsch K.D., and Sommer J. Pharmacokinetics and metabolism of nifedipine. Hypertension 5 (1983) II18-II24
20. Raffin-Sanson M.L., de Keyzer Y., and Bertagna X. Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur. J. Endocrinol. 149 (2003) 79-90
21. von Dreden G., Loeffler J.P., Grimm C., and Hollt V. Influence of calcium ions on proopiomelanocortin mRNA levels in clonal anterior pituitary cells. Neuroendocrinology 47 (1988) 32-37
22. Weissman C. The metabolic response to stress: an overview and update. Anesthesiology 73 (1990) 308-327
23. Wijeysundera D.N., and Beattie W.S. Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: a meta-analysis. Anesth. Analg. 97 (2003) 634-641